Annual ROE
-39.02%
-13.57%-53.32%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual return on equity is -39.02%, with the most recent change of -13.57% (-53.32%) on December 31, 2023.
- During the last 3 years, LTRN annual ROE has fallen by -9.03% (-30.11%).
- LTRN annual ROE is now -104.56% below its all-time high of 855.50%, reached on December 31, 2018.
Performance
LTRN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-56.90%
-10.51%-22.66%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly return on equity is -56.90%, with the most recent change of -10.51% (-22.66%) on September 30, 2024.
- Over the past year, LTRN quarterly ROE has dropped by -26.93% (-89.86%).
- LTRN quarterly ROE is now -255.18% below its all-time high of -16.02%, reached on December 31, 2021.
Performance
LTRN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LTRN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.3% | -89.9% |
| 3 y3 years | -30.1% | -211.6% |
| 5 y5 years | -104.6% | - |
LTRN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -125.9% | at low | -255.2% | at low |
| 5 y | 5-year | -125.9% | +84.8% | -255.2% | +82.8% |
| alltime | all time | -104.6% | +84.8% | -255.2% | +82.8% |
Lantern Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -56.90%(+22.7%) |
| Jun 2024 | - | -46.39%(+12.7%) |
| Mar 2024 | - | -41.17%(+20.7%) |
| Dec 2023 | -39.02%(+53.3%) | -34.11%(+13.8%) |
| Sep 2023 | - | -29.97%(+13.4%) |
| Jun 2023 | - | -26.42%(+7.8%) |
| Mar 2023 | - | -24.50%(+3.7%) |
| Dec 2022 | -25.45% | -23.62%(+5.3%) |
| Sep 2022 | - | -22.44%(-5.3%) |
| Jun 2022 | - | -23.69%(+23.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -19.21%(+19.9%) |
| Dec 2021 | -17.27%(-42.4%) | -16.02%(-12.3%) |
| Sep 2021 | - | -18.26%(-1.2%) |
| Jun 2021 | - | -18.49%(-14.2%) |
| Mar 2021 | - | -21.56%(-40.7%) |
| Dec 2020 | -29.99%(-88.3%) | -36.34%(+14.0%) |
| Sep 2020 | - | -31.87%(-1.1%) |
| Jun 2020 | - | -32.24%(-90.3%) |
| Mar 2020 | - | -331.34%(+28.7%) |
| Dec 2019 | -257.42%(-130.1%) | -257.43% |
| Dec 2018 | 855.50% | - |
FAQ
- What is Lantern Pharma annual return on equity?
- What is the all time high annual ROE for Lantern Pharma?
- What is Lantern Pharma annual ROE year-on-year change?
- What is Lantern Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Lantern Pharma?
- What is Lantern Pharma quarterly ROE year-on-year change?
What is Lantern Pharma annual return on equity?
The current annual ROE of LTRN is -39.02%
What is the all time high annual ROE for Lantern Pharma?
Lantern Pharma all-time high annual return on equity is 855.50%
What is Lantern Pharma annual ROE year-on-year change?
Over the past year, LTRN annual return on equity has changed by -13.57% (-53.32%)
What is Lantern Pharma quarterly return on equity?
The current quarterly ROE of LTRN is -56.90%
What is the all time high quarterly ROE for Lantern Pharma?
Lantern Pharma all-time high quarterly return on equity is -16.02%
What is Lantern Pharma quarterly ROE year-on-year change?
Over the past year, LTRN quarterly return on equity has changed by -26.93% (-89.86%)